Literature DB >> 8877284

The role of interleukin-1 in the pathogenesis of IDDM.

T Mandrup-Poulsen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8877284     DOI： 10.1007/bf00400649

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  302 in total

1.  Interleukin 1 beta increases the cytosolic free sodium concentration in isolated rat islets of Langerhans.

Authors:  S Helqvist; P N Bouchelouche; J Johannesen; J Nerup
Journal:  Scand J Immunol       Date:  1990-07       Impact factor: 3.487

2.  Analysis of IL-2 receptor positive CD8(+)-T-lymphocytes grown from islets of NOD mice.

Authors:  H Huber; P Berschick; H Kolb
Journal:  Diabetes Res       Date:  1991-02

3.  Interleukin-1 beta depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism.

Authors:  D L Eizirik; M Welsh; E Strandell; N Welsh; S Sandler
Journal:  Endocrinology       Date:  1990-11       Impact factor: 4.736

4.  Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation.

Authors:  K D Kröncke; V Kolb-Bachofen; B Berschick; V Burkart; H Kolb
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

5.  Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats.

Authors:  R Kleemann; H Rothe; V Kolb-Bachofen; Q W Xie; C Nathan; S Martin; H Kolb
Journal:  FEBS Lett       Date:  1993-08-09       Impact factor: 4.124

Review 6.  Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM.

Authors:  J A Corbett; M L McDaniel
Journal:  Diabetes       Date:  1992-08       Impact factor: 9.461

7.  Interleukin 1 beta induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthases.

Authors:  J I Reimers; U Bjerre; T Mandrup-Poulsen; J Nerup
Journal:  Cytokine       Date:  1994-09       Impact factor: 3.861

8.  Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells.

Authors:  B Heller; Z Q Wang; E F Wagner; J Radons; A Bürkle; K Fehsel; V Burkart; H Kolb
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

9.  Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes.

Authors:  Y Higuchi; P Herrera; P Muniesa; J Huarte; D Belin; P Ohashi; P Aichele; L Orci; J D Vassalli; P Vassalli
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice.

Authors:  S Trembleau; G Penna; E Bosi; A Mortara; M K Gately; L Adorini
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307
View more
  126 in total

1.  Genetic polymorphism of interleukin-1beta is associated with risk of type 1 diabetes mellitus in children.

Authors:  Dóra Krikovsky; Barna Vásárhelyi; András Treszl; Anna Körner; Attila Tordai; Tivadar Tulassay; László Madácsy
Journal:  Eur J Pediatr       Date:  2002-09       Impact factor: 3.183

Review 2.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

3.  Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells.

Authors:  K L A Souza; M Elsner; P C F Mathias; S Lenzen; M Tiedge
Journal:  Diabetologia       Date:  2004-07-10       Impact factor: 10.122

Review 4.  Blockade of interleukin 1 in type 1 diabetes mellitus.

Authors:  Thomas Mandrup-Poulsen; Linda Pickersgill; Marc Yves Donath
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

Review 5.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

6.  Adenoviral overproduction of interleukin-1 receptor antagonist increases beta cell replication and mass in syngeneically transplanted islets, and improves metabolic outcome.

Authors:  N Téllez; M Montolio; E Estil-les; J Escoriza; J Soler; E Montanya
Journal:  Diabetologia       Date:  2007-01-13       Impact factor: 10.122

7.  Extracellular factors and immunosuppressive drugs influencing insulin secretion of murine islets.

Authors:  V J Auer; E Janas; V Ninichuk; E Eppler; T S Weiss; S Kirchner; A M Otto; M J Stangl
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

8.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Frédéric Ris; José Oberholzer; Helen I Joller-Jemelka; Giatgen A Spinas; Nurit Kaiser; Philippe A Halban; Marc Y Donath
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.

Authors:  Peter A Gottlieb; Aimon K Alkanani; Aaron W Michels; Eli C Lewis; Leland Shapiro; Charles A Dinarello; Danny Zipris
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

10.  Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.

Authors:  Marianne Böni-Schnetzler; Jeffrey Thorne; Géraldine Parnaud; Lorella Marselli; Jan A Ehses; Julie Kerr-Conte; Francois Pattou; Philippe A Halban; Gordon C Weir; Marc Y Donath
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.